Home Featured Page 177

Featured

Latest

Psychedelic Medicine at the Edge of Science and Spirit

Pα+ Psychedelic Bulletin #217: Gilgamesh’s GM-1020 Prints Positive Topline; FDA Lifts Hold on GH Research’s 5-MeO-DMT IND; Compass Details Pivotal PTSD Trial Design; Cybin...

Manvir Singh: Shamanism, the Timeless Religion

2025 Year in Review: Future(s) & Open Questions (Video)

2025 Year in Review: 10 Standout Stories in Psychedelics

Entheon Biomedical Announces Non-Brokered Private Placement Financing

Field Trip Health Ltd. Granted US Patent Covering Novel Psychedelic Molecule...

MindMed Appoints Francois Lilienthal, MD as Chief Commercial Officer

Beckley Psytech Announces Dosing of First Healthy Volunteers in Phase 1...

PT307 – Kathryn L. Tucker, JD – The Right to Try...

Health Canada Approves First Special Access Program Requests for Psilocybin

Psychedelic Bulletin: Bizarre News from Across the Psychedelics Space (April 1,...

Canada’s SAP Expansion Signals a Step Forward for Psychedelics

PT306 – Dr. Devon Christie – Vital Psychedelic Conversations

Mydecine Reports Financial Results for the Fiscal Year 2021 and Provides...

1...176177178...305 Page 177 of 305

Psychedelic Medicine at the Edge of Science and Spirit

Pα+ Psychedelic Bulletin #217: Gilgamesh’s GM-1020 Prints Positive Topline; FDA Lifts...

Manvir Singh: Shamanism, the Timeless Religion

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Psychedelic Medicine at the Edge of Science and Spirit

Pα+ Psychedelic Bulletin #217: Gilgamesh’s GM-1020 Prints Positive Topline; FDA Lifts Hold on GH Research’s 5-MeO-DMT IND; Compass Details Pivotal PTSD Trial Design; Cybin...

Manvir Singh: Shamanism, the Timeless Religion

2025 Year in Review: Future(s) & Open Questions (Video)

2025 Year in Review: 10 Standout Stories in Psychedelics

Entheon Biomedical Announces Non-Brokered Private Placement Financing

Field Trip Health Ltd. Granted US Patent Covering Novel Psychedelic Molecule...

MindMed Appoints Francois Lilienthal, MD as Chief Commercial Officer

Beckley Psytech Announces Dosing of First Healthy Volunteers in Phase 1...

PT307 – Kathryn L. Tucker, JD – The Right to Try...

Health Canada Approves First Special Access Program Requests for Psilocybin

Psychedelic Bulletin: Bizarre News from Across the Psychedelics Space (April 1,...

Canada’s SAP Expansion Signals a Step Forward for Psychedelics

PT306 – Dr. Devon Christie – Vital Psychedelic Conversations

Mydecine Reports Financial Results for the Fiscal Year 2021 and Provides...

EDITOR PICKS

Psychedelic Medicine at the Edge of Science and Spirit

Pα+ Psychedelic Bulletin #217: Gilgamesh’s GM-1020 Prints Positive Topline; FDA Lifts...

Manvir Singh: Shamanism, the Timeless Religion

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY